A Case Study: How the Rephaiah Project Combats Malaria in Young Children

Wilfred Dodoli; Titha Dzowela; Sveinbjörn Gizurarson; Emmanuel Mwathunga; Precious Ngwalero Katundu; Urður Njarðvík; Kristín Linda Ragnarsdóttir; Guðlaug María Sveinbjörnsdóttir

doi:10.1201/9781003035992-17

A Case Study: How the Rephaiah Project Combats Malaria in Young Children

Wilfred Dodoli, Titha Dzowela, Sveinbjörn Gizurarson, Emmanuel Mwathunga, Precious Ngwalero Katundu, Urður Njarðvík, Kristín Linda Ragnarsdóttir, Guðlaug María Sveinbjörnsdóttir

University of Iceland

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

The Rephaiah project is focusing on providing health and hope to these children, by establishing a not-for-profit pharmaceutical manufacturing entity in Malawi. The focus is on pediatric dosage forms for infants and children under the age of 5 years. Establishing a specialized not-for-profit pharmaceutical entity is a major undertaking. There is little or no experience in Malawi in manufacturing drugs from raw materials. The Rephaiah Projects goal is to get this entity running and financially sustainable, while focusing on drug formulations for diseases that impact the lives of young children and their families. In the long run the Rephaiah Project is working on better health for young children, that will in due course, together with Long Lasting Insecticide Nets (LLIN) and other measures taken against the spread of malaria, enable children to do well in school, resulting in better job opportunities and improved quality of life.

Original language	English
Title of host publication	Bio-mathematics, Statistics, and Nano-Technologies
Publisher	Taylor and Francis
Chapter	18
Number of pages	15
DOIs	https://doi.org/10.1201/9781003035992-17
Publication status	Published - 2023

Access to Document

10.1201/9781003035992-17

Cite this

@inbook{7fdbccd4acff4c8dab411449e80ebaa0,

title = "A Case Study: How the Rephaiah Project Combats Malaria in Young Children",

abstract = "The Rephaiah project is focusing on providing health and hope to these children, by establishing a not-for-profit pharmaceutical manufacturing entity in Malawi. The focus is on pediatric dosage forms for infants and children under the age of 5 years. Establishing a specialized not-for-profit pharmaceutical entity is a major undertaking. There is little or no experience in Malawi in manufacturing drugs from raw materials. The Rephaiah Projects goal is to get this entity running and financially sustainable, while focusing on drug formulations for diseases that impact the lives of young children and their families. In the long run the Rephaiah Project is working on better health for young children, that will in due course, together with Long Lasting Insecticide Nets (LLIN) and other measures taken against the spread of malaria, enable children to do well in school, resulting in better job opportunities and improved quality of life.",

author = "Wilfred Dodoli and Titha Dzowela and Sveinbj{\"o}rn Gizurarson and Emmanuel Mwathunga and \{Ngwalero Katundu\}, Precious and Ur{\dh}ur Njar{\dh}v{\'i}k and Ragnarsd{\'o}ttir, \{Krist{\'i}n Linda\} and Sveinbj{\"o}rnsd{\'o}ttir, \{Gu{\dh}laug Mar{\'i}a\}",

year = "2023",

doi = "10.1201/9781003035992-17",

language = "English",

booktitle = "Bio-mathematics, Statistics, and Nano-Technologies",

publisher = "Taylor and Francis",

address = "United States",

}

TY - CHAP

T1 - A Case Study: How the Rephaiah Project Combats Malaria in Young Children

AU - Dodoli, Wilfred

AU - Dzowela, Titha

AU - Gizurarson, Sveinbjörn

AU - Mwathunga, Emmanuel

AU - Ngwalero Katundu, Precious

AU - Njarðvík, Urður

AU - Ragnarsdóttir, Kristín Linda

AU - Sveinbjörnsdóttir, Guðlaug María

PY - 2023

Y1 - 2023

N2 - The Rephaiah project is focusing on providing health and hope to these children, by establishing a not-for-profit pharmaceutical manufacturing entity in Malawi. The focus is on pediatric dosage forms for infants and children under the age of 5 years. Establishing a specialized not-for-profit pharmaceutical entity is a major undertaking. There is little or no experience in Malawi in manufacturing drugs from raw materials. The Rephaiah Projects goal is to get this entity running and financially sustainable, while focusing on drug formulations for diseases that impact the lives of young children and their families. In the long run the Rephaiah Project is working on better health for young children, that will in due course, together with Long Lasting Insecticide Nets (LLIN) and other measures taken against the spread of malaria, enable children to do well in school, resulting in better job opportunities and improved quality of life.

AB - The Rephaiah project is focusing on providing health and hope to these children, by establishing a not-for-profit pharmaceutical manufacturing entity in Malawi. The focus is on pediatric dosage forms for infants and children under the age of 5 years. Establishing a specialized not-for-profit pharmaceutical entity is a major undertaking. There is little or no experience in Malawi in manufacturing drugs from raw materials. The Rephaiah Projects goal is to get this entity running and financially sustainable, while focusing on drug formulations for diseases that impact the lives of young children and their families. In the long run the Rephaiah Project is working on better health for young children, that will in due course, together with Long Lasting Insecticide Nets (LLIN) and other measures taken against the spread of malaria, enable children to do well in school, resulting in better job opportunities and improved quality of life.

U2 - 10.1201/9781003035992-17

DO - 10.1201/9781003035992-17

M3 - Chapter

BT - Bio-mathematics, Statistics, and Nano-Technologies

PB - Taylor and Francis

ER -